drugset / Trial / NCT03324607
Effects of Bevespi on Ventilation and Gas Exchange Abnormalities in COPD Assessed by 129Xe MRI
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to determine whether the new inhaler, Bevespi improves lung function. Magnetic resonance imaging (MRI) using inhaled hyperpolarized 129Xe gas, that can provide useful images of the functioning of the lung will be used as a new measure to determine change in function. The investigator anticipate these images will provide more specific information about lung disease than standard lung function tests in response to treatment.
Timeline
- Start
- 2018-04-20
- Primary completion
- 2019-11-12
- Completion
- 2019-11-12
Outcome
Met primary endpoint
registry analysis (other test); Treatment; p = 0.006; Paired t-test NCT03324607 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrrolate/Formoterol | Unknown | — | Inhaled |